AA
AVNS

Addison Advisors’s Avanos Medical AVNS Stock Holding History

Addison Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50
Closed -$701 – 725
2026
Q1 		$701 Hold
50
– – ﹤0.01% 909
2025
Q4 		$562 Hold
50
– – ﹤0.01% 862
2025
Q3 		$578 Hold
50
– – ﹤0.01% 842
2025
Q2 		$612 Hold
50
– – ﹤0.01% 834
2025
Q1 		$717 Hold
50
– – ﹤0.01% 790
2024
Q4 		$796 Hold
50
– – ﹤0.01% 792
2024
Q3 		$1.2K Hold
50
– – ﹤0.01% 763
2024
Q2 		$996 Hold
50
– – ﹤0.01% 718
2024
Q1 		$996 Buy
+50
New +$967 ﹤0.01% 647

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Addison Advisors's AVNS Position: Q2 2026 in Review

Addison Advisors sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 50 shares — an estimated $701 sold.

Addison Advisors first reported a position in AVNS in Q1 2024 and held it in 9 quarters. The position peaked at $1.2K in Q3 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Addison Advisors reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Addison Advisors sold 50 Avanos Medical shares in Q2 2026, an estimated $701.
  • Addison Advisors first reported a position in Avanos Medical in Q1 2024 and held it in 9 quarters.
  • Addison Advisors's Avanos Medical position peaked at $1.2K in Q3 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.